What's Happening?
Researchers in Germany have discovered that therapeutic apheresis, a treatment primarily used to remove excess fats from the blood of cardiovascular patients, may also reduce levels of certain synthetic chemicals and microplastics. The study, published
in Brain Health, found that the procedure could lower the presence of per- and polyfluoroalkyl substances (PFAS) and some microplastics in the blood. PFAS, often referred to as 'forever chemicals', are used in various consumer products and are known for their persistence in the environment and human body. The study involved 14 patients undergoing double filtration plasmapheresis, which showed a reduction in PFAS levels by up to 25% immediately after treatment. However, the findings on microplastics were inconsistent, with some levels decreasing and others increasing post-treatment.
Why It's Important?
The potential of therapeutic apheresis to remove environmental pollutants like PFAS and microplastics from the bloodstream could have significant implications for public health. PFAS exposure has been linked to various health issues, including increased cholesterol levels, immune and hormonal changes, and certain cancers. The ability to reduce these substances in the blood could offer a new avenue for mitigating their health impacts. However, the study's small sample size and inconsistent results highlight the need for further research. If proven effective, this treatment could become a valuable tool in addressing the growing concern over environmental pollutants and their effects on human health.
What's Next?
Further research is needed to confirm the efficacy of therapeutic apheresis in consistently removing PFAS and microplastics from the blood. Larger controlled trials with standardized measurements and longer follow-up periods are necessary to determine the treatment's potential as a method for reducing environmental pollutant exposure. Additionally, the medical community will need to assess the cost-effectiveness and practicality of implementing this treatment on a broader scale. As awareness of the health risks associated with PFAS and microplastics grows, there may be increased demand for solutions that can mitigate their presence in the human body.
